Архивъ внутренней медицины (Aug 2012)

Клиническая эффективность коррекции метаболических нарушений у больных ишемической болезнью сердца на фоне диабетической нефропатии с применением гликозаминогликанов

  • Л. В. Козлова,
  • Р. А. Хохлов

DOI
https://doi.org/10.20514/2226-6704-2012-0-4-28-33
Journal volume & issue
Vol. 0, no. 4
pp. 28 – 33

Abstract

Read online

We have studied the clinical efficacy of Sulodexide in patients with diabetes mellitus type 2 and coronary heart disease in the context of prevention of contrast-induced nephropathy (CIN). Inclusion of Sulodexide in the complex therapy of patients with coronary artery disease and type 2 diabetes requiring intervention measures creates the preconditions for reducing the incidence of CIN and prevention of kidney function, providing antiproteinuric effect, correcting lipid metabolism, blood coagulation system.

Keywords